when will bpc 157 be approved What do we know about 'research only' peptides? Q&A with expert Stuart Phillips The Human Lab Rats Injecting

The SURPASS program (for type 2 diabetes) and SURMOUNT program (for obesity) together enrolled over 20,000 participants across multiple Phase III trials

Holding the open ampuole at an angle in one hand, use the other hand to carefully place the needle near the bottom and draw-up the B12

Have Questions

Fill out the form below and our team will reach out to answer your questions about the AOD-9604 program

Their modular amino acid architecture enables highly selective interactions with receptors, enzymes, and signaling networks under investigation

How They Work Support hepatic fat metabolism via MIC compounds Deliver nutrients at 100% IM absorption Support liver function and fat export Inositol sensitizes insulin signaling B12 restores metabolic energy foundation Best results as part of a broader protocol What Patients Report Improved energy levels often from week 1 Reduced afternoon fatigue Improved exercise capacity and recovery Reduced carbohydrate cravings (inositol) More consistent weight management progress Results vary with diet, exercise, and baseline How They Differ GLP-1: appetite suppression + glucose regulation Lipotropic: fat metabolism + liver function Not competitive different mechanisms Commonly combined for complementary support B12 addresses fatigue GLP-1 patients experience Inform your NP of all current medications Benefits of B12 & Lipotropic Injections